A detailed history of Rossmore Private Capital transactions in Abb Vie Inc. stock. As of the latest transaction made, Rossmore Private Capital holds 42,929 shares of ABBV stock, worth $7.54 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares
42,929
Previous 41,930 2.38%
Holding current value
$7.54 Million
Previous $7.19 Million 17.88%
% of portfolio
1.05%
Previous 0.95%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$163.84 - $199.33 $163,676 - $199,130
999 Added 2.38%
42,929 $8.48 Million
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $88,849 - $103,756
-574 Reduced 1.35%
41,930 $7.19 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $61,211 - $69,744
-383 Reduced 0.89%
42,504 $7.74 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $8,549 - $9,897
64 Added 0.15%
42,887 $6.39 Million
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $248,588 - $309,352
1,876 Added 4.58%
42,823 $5.77 Million
Q1 2023

May 02, 2023

BUY
$144.61 - $166.54 $15,039 - $17,320
104 Added 0.25%
40,947 $6.53 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $22,129 - $26,539
160 Added 0.39%
40,843 $6.6 Million
Q3 2022

Nov 07, 2022

BUY
$134.21 - $153.93 $169,373 - $194,259
1,262 Added 3.2%
40,683 $5.46 Million
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $150,969 - $191,931
1,097 Added 2.86%
39,421 $6.04 Million
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $358,457 - $444,745
2,716 Added 7.63%
38,324 $6.21 Million
Q4 2021

Feb 07, 2022

BUY
$107.43 - $135.93 $429 - $543
4 Added 0.01%
35,608 $4.82 Million
Q3 2021

Nov 08, 2021

BUY
$106.4 - $120.78 $8,937 - $10,145
84 Added 0.24%
35,604 $3.84 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $89,323 - $99,511
849 Added 2.45%
35,520 $4 Million
Q1 2021

May 10, 2021

SELL
$102.3 - $112.62 $124,601 - $137,171
-1,218 Reduced 3.39%
34,671 $3.75 Million
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $176,836 - $238,747
2,197 Added 6.52%
35,889 $3.85 Million
Q3 2020

Nov 10, 2020

BUY
$85.91 - $100.83 $34,364 - $40,332
400 Added 1.2%
33,692 $2.95 Million
Q2 2020

Aug 05, 2020

BUY
$73.37 - $98.18 $215,047 - $287,765
2,931 Added 9.65%
33,292 $3.27 Million
Q1 2020

May 07, 2020

BUY
$64.5 - $97.79 $270,061 - $409,446
4,187 Added 16.0%
30,361 $2.31 Million
Q4 2019

Feb 10, 2020

BUY
$72.13 - $90.25 $398,518 - $498,631
5,525 Added 26.76%
26,174 $2.32 Million
Q2 2019

Aug 05, 2019

BUY
$65.7 - $83.98 $362,992 - $463,989
5,525 Added 36.53%
20,649 $1.5 Million
Q1 2019

Apr 30, 2019

SELL
$77.14 - $90.79 $37,412 - $44,033
-485 Reduced 3.11%
15,124 $1.22 Million
Q4 2018

Jan 22, 2019

BUY
$77.85 - $96.01 $31,139 - $38,404
400 Added 2.63%
15,609 $1.44 Million
Q3 2018

Oct 26, 2018

BUY
$88.91 - $98.84 $614,368 - $682,984
6,910 Added 83.26%
15,209 $1.44 Million
Q2 2018

Jul 20, 2018

BUY
$89.78 - $106.23 $115,636 - $136,824
1,288 Added 18.37%
8,299 $769,000
Q1 2018

May 04, 2018

BUY
$92.01 - $123.21 $185,124 - $247,898
2,012 Added 40.25%
7,011 $664,000
Q4 2017

Mar 15, 2018

BUY
$89.56 - $98.21 $447,710 - $490,951
4,999
4,999 $483 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Rossmore Private Capital Portfolio

Follow Rossmore Private Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rossmore Private Capital, based on Form 13F filings with the SEC.

News

Stay updated on Rossmore Private Capital with notifications on news.